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Abstract
The electrically evoked release of acetylcholine and its
modulation via auto- and heteroreceptors were studied in
primary cell cultures prepared from embryonic rat septum
(ED 17). Cultures were grown for 1, 2 or 3 weeks on circular,
poly D-lysine-coated glass coverslips. They developed a
dense network of non-neuronal and neuronal cells, only
some of which were immunopositive for choline acetyltrans-
ferase. To measure acetylcholine release, the cells on the
coverslips were pre-incubated with [3H]choline (0.1 mmol/L),
superfused with modi®ed Krebs±Henseleit buffer at 258C and
electrically stimulated twice for 2 min (S1, S2; 3 Hz, 0.5 ms,
90±100 mA). The electrically evoked over¯ow of [3H] from the
cells consisted of < 80% of authentic [3H]Ach, was largely
Ca21-dependent and tetrodotoxin sensitive, and hence
represents an action potential-evoked, exocytotic release of
acetylcholine. Using pairs of selective agonists and antagon-
ists added before S2, muscarinic autoreceptors, as well as
inhibitory adenosine A1- and opioid m-receptors, could be
detected, whereas d-opioid receptors were not found. Evoked
[3H] over¯ow from cultures grown for 1 week, although Ca21
dependent and tetrodotoxin sensitive, was insensitive to the
muscarinic agonist oxotremorine, whereas the effect of
oxotremorine on cells grown for 3 weeks was even more
pronounced than that in 2-week-old cultures. In conclusion,
similar to observations on rat septal tissue in vivo, acetyl-
choline release from septal cholinergic neurones grown in vitro
is inhibited via muscarinic, adenosine A1 and m-opioid
receptors. This in vitro model may prove useful in the
exploration of regulatory mechanisms underlying the expres-
sion of release modulating receptors on septal cholinergic
neurones.
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Cholinergic innervation of the hippocampus originates
mainly from the medial septum and the diagonal band of
Broca (Amaral and Witter 1995; Jakab and Leranth 1995).
The release of acetylcholine (Ach) in the target area of this
projection, the hippocampus, has been shown to be modu-
lated via muscarinic autoreceptors (Starke et al. 1989) and
various heteroreceptors. For example, m-opioid receptors
(Jackisch et al. 1986; Lapchak et al. 1990; Jackisch 1991)
and adenosine A1-receptors (Jackisch et al. 1984; Duner-
Engstrom and Fredholm 1988; Cunha et al. 1994) have been
found on cholinergic axon terminals in the hippocampus. In
the cell body region of the septohippocampal projection, the
medial septum and the diagonal band of Broca, we observed
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that the evoked release of Ach was inhibited via muscarinic
autoreceptors (Disko et al. 1998, 1999), as well as via m-
and d-opioid receptors (Gazyakan et al. 2000a) and
adenosine A1-receptors (unpublished observations).
Little is known about the perinatal expression and
development of presynaptic receptors on cholinergic
neurones of the CNS. Marchi et al. (1983) followed the
development of muscarinic autoreceptors on synaptosomes
of the rat neocortex, whereas DeVries et al. (1990) and
Perez-Navarro et al. (1993) studied the ontogeny of various
presynaptic receptors on cholinergic nerve terminals in the
rat striatum. Using the technique of electrically evoked Ach
release from brain slices, we recently reported on the
postnatal development of presynaptic muscarinic and opioid
receptors on cholinergic neurones in the hippocampus and
the septum of the rat (Disko et al. 1998, 1999; Goldbach
et al. 1998; Gazyakan et al. 2000b).
Although the time course of the postnatal appearance of
presynaptic receptors could be established in the studies
mentioned above, the signals and events regulating their
expression remain to be clari®ed. Such regulatory mechan-
isms can, however, be studied more easily on neuronal
systems in vitro (HeÂry et al. 1999). Therefore, the ®rst aim
of this study was to investigate the basic properties of a cell
culture model (septal cholinergic neurones) in which
electrically evoked Ach release and its modulation could
be measured. Secondly, we wanted to ®nd out which of the
presynaptic receptors found on cholinergic cells in vivo, i.e.
in the cell body or the target area of the septohippocampal
pathway (see above), are also detectable in vitro, i.e. in
cultures of septal cholinergic neurones.
Materials and methods
Materials
Chemicals and drugs were purchased from the following sources:
[methyl-3H]choline chloride (85 Ci/mmol) and [14C]acetyl
coenzyme A (51 mCi/mmol) from Amersham-Pharmacia
(Braunschweig, Germany); ATP, N6-cyclopentyladenosine (CPA),
1,8-dipropyl-8-cyclopentylxanthine (DPCPX), methiotepine mesy-
late (metitepine), naloxone hydrochloride and poly d-lysine from
RBI (Biotrend) (KoÈln, Germany); acetylcholinesterase (AchE;
EC 3.1.1.7) type VI-S from electric eel, atropine sulfate, choline
oxidase (EC 1.1.3.17) from Alcaligenes species, hemicholinium-3,
oxotremorine sesquifumarate, paraoxon and tetrodotoxin from
Sigma-Aldrich (MuÈnchen, Germany); (d-Ala2, N-Me-Phe4,
glycinol5)-enkephalin (DAGO), (D-Pen2, D-Pen5)-enkephalin
(DPDPE) from Bachem (Heidelberg, Germany); and sodium
tetraphenyl borate and butyronitrile from Merck (Darmstadt,
Germany). Sources for products used for cell cultivation and
immunocytochemistry are indicated below.
Preparation of septal cell cultures
Pregnant Wistar rats on embryonic day 17 (ED 17) were
anaesthetized with sodium pentobarbital, the embryos were
removed and their brains dissected under a stereomicroscope
according to Svendsen (1995). Tissue pieces containing the septal
region were collected in ice-cold phosphate-buffered saline
(Biochrom KG, Berlin, Germany) and dissociated by incubation
for 20 min at 378C in 1 mL of trypsin-EDTA solution (0.5%;
Sigma-Aldrich). Trypsinization was stopped by the addition of
500 mL Viable AC-2 medium (Pan Systems; NuÈrnberg, Germany).
Cells were subsequently dissociated by gentle trituration using a
®re-polished Pasteur pipette. The suspension was centrifuged at
200 g for 5 min and the pellet resuspended in 1 mL growth
medium (see below). This suspension was re-centrifuged (200 g,
5 min) and resuspended in the ®nal volume (125 mL for cells
obtained from one septum) of growth medium (see below) required
to yield < 650 000 cells/cm2 (counted before plating of the
suspension). Cells were plated onto 90-well plates containing 1
circular (5 mm diameter) glass coverslip precoated with poly
d-lysine (Sigma-Aldrich) per well. In some experiments 10 mL of a
more concentrated cell suspension (17.5 mL for cells obtained from
one septum) were pipetted directly onto each of 12 glass coverslips
on the bottom of Petri dishes (35 mm diameter; Falcon/Schubert;
MuÈnchen, Germany). After incubation of these dishes for 2 h at
378C in a humidi®ed 95% air/5% CO2 atmosphere, 1.2 mL of
growth medium was carefully added to the culture dish.
Cells were cultured at 378C in a humidi®ed 95% air/5% CO2
atmosphere for 7, 14 or 21 days [day in vitro (DIV) 7, 14 or 21) in
Dulbecco's modi®ed Eagle's medium (Nut. Mix. F-12 with
Glutamax-1, GibcoBRL, Life Technologies, Eggenstein, Germany)
containing 10% Viable AC-2, a mixture of insulin, transferrin and
sodium selenite (5 mg/mL, 5 mg/mL and 5 ng/mL; Sigma-Aldrich),
a mixture of penicillin and streptomycin (50 U/mL and 50 mg/mL;
GibcoBRL), as well as mouse nerve growth factor (mNGF; 10 ng/
mL) and human neurotrophin-3 (hNT3; 50 ng/mL; Alomone/ICS,
MuÈnchen, Germany). The growth medium was changed every
3±4 days.
Immunostaining of cells
Acetyl-CoA : choline O-acetyltransferase (EC 2.3.1.6), choline
acetyltransferase
Cultured cells were washed with 0.1 mol/L sodium phosphate
buffer (pH 7.35) and ®xed with sodium phosphate buffer contain-
ing 4% paraformaldehyde and 0.2% picric acid. Following ®xation,
cultures were washed for 30±60 min and then incubated for 2 days
at 48C with choline acetyltransferase (ChAT) rat monoclonal
antibody (1 mg/mL; Boehringer, Mannheim, Germany), 0.1%
Triton X-100, 0.1% sodium azide and 1% rabbit serum in sodium
phosphate buffer. Cultures were washed with sodium phosphate
buffer (60 min) and incubated with biotinylated antirat antibody
(1 : 230; Vector Laboratories; Burlingham, USA) in sodium
phosphate buffer for < 12 h. The cells were subsequently washed
and incubated with an avidin±biotin conjugate of peroxidase
(Vectastain, Vector Laboratories) for 2 h and then washed again.
Peroxidase was visualized using diaminobenzidin (0.7 mg/mL;
Sigma-Aldrich) and hydrogen peroxide (0.1%).
Glial ®brillary acidic protein
The glial marker was visualized according to Manthorpe et al.
(1979). Cultures were ®xed with 4% paraformaldehyde in sodium
phosphate buffer (30 min) then washed and treated with 4% normal
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goat serum (Vector Laboratories) and 0.1% Triton X-100. There-
after the cells were incubated for 12 h at 48C with glial ®brillary
acidic protein polyclonal rabbit antibody (1 : 600; Boehringer) and
then stained by the addition of Cy2-conjugated goat antirabbit
antibody (1 : 600; Jackson Immunoresearch Laboratories; West
Grove, USA) for 2 h. Washes in between steps were carried out
with phosphate-buffered saline.
Microtubule-associated protein
To visualize neuronal microtubule-associated protein II (MAPII) a
mouse monoclonal antibody was used (1 : 200; Sigma-Aldrich).
The cultures were ®xed and washed as described for GFAP
immunostaining. As a second antibody, goat antimouse IgG
conjugated with Cy3 (1 : 600; Rockland, Gilbertsville, USA)
was used and incubated for 2 h. The stained cultures were
washed with water and mounted in moviol (Hoechst, Frankfurt,
Germany).
Determination of ChAT activity
Cultured septal cells (from four glass coverslips per sample), grown
for various DIV were carefully scraped off, homogenized in
400 mL 0.32 mole/L sucrose (in 2.5 mmol/L HEPES, pH 7.4) and
stored at 2808C until determination. The ChAT activity in
these samples was measured according to Fonnum (1975) as
described in detail previously (Cassel et al. 1993). The protein
content of the cell homogenates was assessed according to Lowry
et al. (1951).
Fig. 2 Time course of the development of choline acetyltransferase
(ChAT) activity in septal cell cultures during growth (n  6±12 single
determinations from two independent cell cultures).
Fig. 1 Microscopic aspects of septal cell
cultures. Phase contrast microscopic aspect
of septal cells cultured for (a) 7, (b) 14 or
(c) 21 days in vitro. Immunostaining of
septal cells (DIV 14) for the (d) glial marker
glial ®brillary acidic protein (GFAP), (e) the
neuronal marker microtubule-associated
protein II (MAPII) or (f) the cholinergic
marker choline acetyltransferase (ChAT).
The bar in a±d represents 100 mm, that in
(e) and (f) represents 20 mm.
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Electrically evoked release of acetylcholine
Twenty-four circular coverslips with septal cells (cell culture
discs), grown for 7, 14 or 21 days (DIV 7, 14 or 21), were
transferred to a 35-mm Petri dish ®lled with cooled, modi®ed
Krebs±Henseleit buffer [composition in mmol/L: NaCl, 118; KCl,
4.8; CaCl2, 1.3; MgSO4, 1.2; NaHCO3, 25; KH2PO4, 1.2; glucose,
11; ascorbic acid, 0.57; Na2EDTA, 0.03; saturated with carbogen
(95% O2, 5% CO2), pH adjusted to 7.4] and washed carefully with
this medium two or three times. The cell culture discs were
subsequently incubated for 30 min at 378C in 2 mL Krebs±
Henseleit buffer containing [3H]choline (0.1 mmol/L) under an
atmosphere of carbogen. Following incubation they were washed
with prewarmed and gassed Krebs±Henseleit buffer, transferred to
12 superfusion chambers (two cell culture discs, back to back, per
chamber) and superfused continuously with Krebs±Henseleit
buffer (258C, gassed with carbogen) at a rate of 0.6 mL/min in
the presence of hemicholinium-3 (10 mmol/L). The collection of
4-min fractions was started after 45 min of superfusion; electrical
®eld stimulation for 2 min (360 rectangular pulses, 3 Hz, 0.5 ms,
90±100 mA, 8.5 V/chamber) was applied after 57 min (S1) and
89 min (S2) of superfusion. Drugs to be tested were added to the
superfusion medium from 20 min (Ca21-free medium) or 16 min
(all other drugs) before S2 onwards. At the end of the experiment
(after 107 min of superfusion), the radioactivity of the superfusate
samples and the cell culture discs (cells dissolved in 250 mL
Soluene 350; Packard) was determined using liquid scintillation
counting.
Determination of the [3H]Ach content in the basal [3H]ef¯ux and
the electrically evoked [3H]over¯ow of the cultured cells was
performed in separate experiments. Cultured cells (DIV 14) were
pre-incubated with [3H]choline as above for 30 min. Subsequently,
50 mm paraoxon (to irreversibly block AchE in the cultures) was
added and the cells were incubated for a further 15 min. Finally,
they were washed, superfused (in the absence of paraoxon, but the
presence of hemicholinium-3, 10 mmol/L) and stimulated electri-
cally once only (S1) as described above. Aliquots (800 mL) of the
superfusate fractions were counted directly to determine total
[3H]out¯ow (value A). Two further aliquots (800 mL each) of
fractions 53±57 min (b1) and 57±61 (S1) min of superfusion were
incubated (20 min at 378C) with 80 mL of a mixture containing
either (value B) choline oxidase (1.6 U in 500 mmol/L Tris,
pH 8.0) or (value C) choline oxidase (1.6 U) plus AchE (3.2 U in
500 mmol/L Tris pH 8.0). At the end of the incubation, 500 mL of
sodium tetraphenyl borate in butyronitrile (10 mg/mL) was added,
and the mixture was shaken vigorously for 2 min and centrifuged
for 5 min (22 800 g). Three hundred microlitres of the upper
(organic) phase were taken for liquid scintillation counting. From
the differences between value B ([3H]choline removed by choline
oxidase: only [3H]Ach extracted into the organic phase) and value
C (both [3H]choline and [3H]Ach enzymatically removed: the
organic phase contains only nonspeci®cally extracted [3H]) the
amount of [3H]Ach in the superfusate samples was calculated as a
percentage of the total radioactivity (value A) in the superfusate
fraction.
Calculations and statistics
The fractional rate of tritium out¯ow (% cell tritium per min)
was calculated as: (pmoles tritium out¯ow per 4 min)  100/
4  (pmoles tritium in the `cell culture discs' at the start of the
respective 4-min period). The stimulation-evoked over¯ow of
tritium was calculated by subtracting the basal out¯ow; the latter
was assumed to decline linearly from 4 min before to the 4-min
period 12±16 min after the onset of the stimulation. The evoked
over¯ow was expressed as the per cent of the tritium content of the
cell culture discs at the onset of the respective stimulation period.
The effects of drugs added before S2 were determined as the ratio
of the over¯ow evoked by the corresponding stimulation periods
(S2/S1) and compared with the appropriate control ratios (same age
of culture; no drug addition before S2). The effects of drugs added
before S2 on the basal out¯ow of [
3H] were determined as the ratio
(b2/b1) of the fractional rates of [
3H]out¯ow of the fractions
preceding the two stimulation periods and compared with the
appropriate control ratios (same age of culture; no drug addition
before S2). Estimation of the IC50 and the maximal inhibitory effect
of oxotremorine at the muscarinic autoreceptor were performed
using non-linear regression analysis (Feuerstein et al. 1993) of the
individual S2/S1 ratios, which are shown as means ^SEM. The
question of whether endogenous Ach competes with oxotremorine
Fig. 3 Time course of [3H]out¯ow from septal cell cultures (DIV 14):
effects of Ca21-free medium and tetrodotoxin (TTX). Septal cells
cultured on glass coverslips for 14 days were pre-incubated with
[3H]choline and then superfused continuously with medium contain-
ing hemicholinium-3 (10 mmol/L). During superfusion they were
stimulated electrically twice after 57 min (S1) and 89 (S2) min of
superfusion, as indicated by the black bars. Calcium was omitted
from, or tetrodotoxin (0.3 mmol/L) added to, the medium from 20 or
16 min, respectively, before S2 onwards. For the amount of [
3H]over-
¯ow evoked by S1 and the extent of drug effects on the S2/S1 ratio
see Fig. 4.
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at the autoreceptor was studied using another linear regression
analysis model (Feuerstein et al. 1987, 1992).
Signi®cance of differences was tested using anova followed by
Bonferroni's test or nonparametric anova (Kruskal±Wallis test)
followed by Dunn's test. All data are shown as means ^SEM; n is
the total number of cell culture discs in at least four independent
superfusion experiments (i.e. from four independent cell cultures).
Results
Morphological aspect of septal cell cultures
Dissociated septal cells (from ED 17) grew well in medium
supplemented with mouse NGF and human NT-3 on circular
poly D-lysine-coated glass coverslips. By 18 h after seeding,
many cells had started to produce extensions from their cell
bodies (not shown). After 7 days in vitro (DIV 7), multiple
aggregates of cells could be observed on the coverslips,
aggregates which were extensively linked to each other by
multiple neurites (Fig. 1a). During further growth, the
density of this network and the number of cells per
aggregate increased, so that the circular glass discs were
covered almost completely by a multilayer cellular
network at DIV 14 (Fig. 1b); over the next week (DIV 21)
the density of this network appeared to increase further
(Fig. 1c).
As evident from immunocytochemical staining of the
cells around DIV 14 (i.e. the time when most of the func-
tional experiments were performed), these septal cultures
consisted of a network of neuronal and non-neuronal cells.
For example, using an antibody for GFAP (Fig. 1d), the
presence of glial cells in the aggregates was evident,
whereas staining for the neuronal marker protein MAPII
(Fig. 1e) revealed a large number of neuronal cells in the
network, some of which contained the GABAergic marker
glutamate decarboxylase (not shown). Finally, as revealed
by staining with ChAT antibodies (Fig. 1f ), a signi®cant
number of cholinergic cells was detectable in or between the
cell clusters. Because of the high density of the cellular
network, however, it was not possible to quantify the
number of cholinergic cells compared with other neuronal or
non-neuronal cells. Nevertheless, as shown in Fig. 2, the
amount of enzymatically determined ChAT activity
increased signi®cantly during growth of septal cell cultures
in vitro.
Electrically evoked release of acetylcholine
General properties and modulation via muscarinic
autoreceptors
Pre-incubation of septal cells (DIV 14) with [3H]choline,
followed by continuous superfusion (in the presence of
hemicholinium-3) and electrical ®eld stimulation, led to the
pattern of [3H]out¯ow shown in Fig. 3. It is evident that
electrical ®eld stimulation induced an [3H]out¯ow that was
signi®cantly higher than the basal [3H]out¯ow. This
`stimulation-evoked [3H]over¯ow' was Ca21 dependent
and sensitive to the presence of tetrodotoxin (see below).
In separate experiments on septal cells cultured for 2 weeks
(DIV 14) we also determined the amount of authentic
[3H]Ach in the tritiated out¯ow, both in the fraction
preceding S1 (fraction 2 in Fig. 3: basal [
3H]out¯ow) and
in the fraction during which electrical ®eld stimulation was
Fig. 4 Basic properties of the transmitter release model. Summary
of experiments on septal cell cultures (DIV 7, 14 and 21) pre-
incubated, superfused and electrically stimulated as shown in Fig. 3.
(a) Accumulation of [3H]choline and electrically evoked [3H]over¯ow
at S1. Signi®cance of differences between [
3H]choline accumulation
values (pmoles [3H]choline per cell culture disc): DIV 7 versus
DIV 14: p , 0.001; DIV 14 versus DIV 21: n.s.; signi®cance of differ-
ences in between S1 values: DIV 7 versus DIV 14: p , 0.001;
DIV 14 versus DIV 21: p , 0.01. (b) Effects of Ca21-free medium,
tetrodotoxin (0.3 mmol/L) and oxotremorine (1 mmol/L) on the electri-
cally evoked [3H]over¯ow at S2. Effects are shown as the ratio S2/S1
as a percentage of the corresponding drug-free controls (symbols
with error bars at the dotted 100% reference line). Signi®cance ver-
sus corresponding controls: ***p , 0.001; **p , 0.01; signi®cance in
between drug effects at different cultivation delays: Ca21-free med-
ium and tetrodotoxin: DIV 7 versus DIV 14: n.s.; DIV 14 versus
DIV 21: n.s.; oxotremorine: DIV 7 versus DIV 14: p , 0.01; DIV 14
versus DIV 21: p , 0.05.
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performed (fraction 3 in Fig. 3; from this value the `evoked
[3H]over¯ow' was calculated by subtraction of fraction 2). It
was found (values are given as a percentage of the total
radioactivity in the corresponding fractions) that the basal
[3H]out¯ow consisted of 15.8 ^ 1.2% [3H]Ach, whereas the
evoked [3H]over¯ow consisted of 78.0 ^ 4.6% of [3H]Ach
(n  14, each; two independent experiments on two
different septal cultures).
Figure 4 summarizes experiments on septal cells
cultivated for 7, 14 or 21 days, pre-incubated with
[3H]choline, superfused and electrically stimulated as
shown in Fig. 3. The accumulation of [3H]choline (pmoles
3H-choline/cell culture disc) increased signi®cantly
(p , 0.001) between 1- and 2-week-old cultures, but
remained unchanged following one additional week of
culture (Fig. 4a). The evoked over¯ow of [3H] at S1 was
signi®cantly lower at DIV 7 and 21 than at DIV 14 both
in relative terms (i.e. S1 as a percentage of cell-
3H, see
Fig. 4a legend) and in absolute terms [i.e. S1 in nCi:
DIV 7 (n  45), 0.242 ^ 0.028, p , 0.001 versus DIV 14
(n  183), 1.167 ^ 0.048, p , 0.001 versus DIV 21
(n  94), 0.839 ^ 0.049]. In contrast, the basal out¯ow
rate of [3H] in the fraction preceding S1 (i.e. 53±57 min
of superfusion, b1) did not differ in septal cell cultures
grown in vitro for 1, 2 or 3 weeks [b1 as a percentage of
cell-3H/min: DIV 7, 0.128 ^ 0.010 (n  45); DIV 14,
0.128 ^ 0.003 (n  183); DIV 21, 0.135 ^ 0.004
(n  94)].
Figure 4(b) shows the effects of Ca21-free medium,
tetrodotoxin (0.3 mmol/L) and the muscarinic autoreceptor
agonist oxotremorine (1 mmol/L) on the electrically evoked
over¯ow of [3H] from septal cells. It is evident that the
evoked over¯ow of [3H] was signi®cantly dependent on the
presence of extracellular Ca21 (open bars) and strongly
reduced in the presence of tetrodotoxin (0.3 mmol/L; solid
bars) at all developmental stages of the cultures. It should be
mentioned, however, that omission of Ca21 (see also Fig. 3)
also slightly increased the basal out¯ow of [3H] in
experiments on 2- and 3-week-old cultures [b2/b1 ratios as
a percentage of corresponding controls: DIV 7, 107 ^ 5
(n  12; n.s.); DIV 14, 123 ^ 5 (n  30; p , 0.001);
DIV 21, 119 ^ 3 (n  28; p , 0.01)].
The muscarinic agonist oxotremorine (1 mmol/L; black
columns in Fig. 4b) did not inhibit the evoked [3H]over¯ow
at DIV 7, whereas at DIV 14 a signi®cant inhibitory effect
(<30%) was observed, which further increased signi®cantly
Fig. 5 Effects of oxotremorine on the electrically evoked [3H]over-
¯ow from septal cell cultures pre-incubated with [3H]choline. Septal
cells (DIV 14) were pre-incubated, superfused and stimulated as
shown in Fig. 3. Oxotremorine was added to the medium in concen-
trations shown on the abscissa from 16 min before S2 onwards. Its
effects are expressed as a percentage of the corresponding drug
free controls (small symbol with error bars at the dotted 100% refer-
ence line). (Inset) Effects of oxotremorine (O, 1 mmol/L), atropine (A,
1 mmol/L) and a combination of both (O 1 A, 1 mmol/L each) as
expressed in percentage of the corresponding controls (small symbol
with error bars at the dotted 100% reference line). Signi®cance of
differences versus drug-free controls: ***p , 0.001, **p , 0.01,
*p , 0.05.
Fig. 6 Effects of the d-opioid receptor agonist (D-Pen2, D-Pen5)-
enkephalin (DPDPE; 1 mmol/L), the m-opioid receptor agonist D-Ala2,
N-Me-Phe4, glycinol5)-enkephalin (DAGO; 1 mmol/L) and the prefer-
ential m-receptor antagonist naloxone (0.1 mmol/L) on the electrically
evoked [3H]over¯ow from septal cell cultures pre-incubated with
[3H]choline. Septal cells (DIV 14) were pre-incubated, superfused
and stimulated as shown in Fig. 3. Opioid receptor agonists and
antagonists were added to the medium from 16 min before S2
onwards. Their effects are expressed as the percentage of the corre-
sponding drug free controls (small symbol with error bars at the
dotted 100% reference line). Signi®cance of differences versus drug-
free controls: ***p , 0.001, *p , 0.05, or versus DAGO 1 mmol/L,
given alone: 111p , 0.001.
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(p , 0.05) following an additional 1 week's culture (at
DIV 21, < 42% inhibition). The inhibitory effect of oxo-
tremorine was studied in more detail on septal cells cultured
for 2 weeks and a sigmoid concentration±response relation-
ship of oxotremorine was observed (Fig. 5). Non-linear
regression analysis of the data shown in Fig. 5 yielded an
IC50 of 0.86 mmol/L (95% con®dence interval: 0.57;
1.40 mmol/L) and a maximal inhibitory effect of oxo-
tremorine (as percentage of controls) of 54% (95%
con®dence interval: 48; 64); the slope parameter c of the
®tted curve was found to be around unity [c  1.10 (95%
con®dence interval: 0.73, 1.78)]. Non-linear regression
analysis of the same data using another model (Feuerstein
et al. 1987, 1992), which permits estimation of the con-
centration of endogenous Ach at the autoreceptor during
the ®rst stimulation, did not reveal any signi®cant
inhibitory tone of the endogenous agonist at the auto-
receptor. Figure 5 (insert) shows that the effect of
oxotremorine (1 mmol/L) was abolished in the presence of
atropine (1 mmol/L), which when given alone did not affect
the evoked [3H]over¯ow. It should also be noted that
physostigmine (1 mmol/L), an inhibitor of AchE
(EC 3.1.1.7), did not signi®cantly diminish the evoked
[3H]over¯ow (data not shown).
Modulation via heteroreceptors
The possible presence of further receptors modulating Ach
release from septal cells cultured in vitro was studied only
on 2-week-old cultures (DIV 14) pre-incubated with
[3H]choline. Figure 6 shows the effects of opioid receptor
agonists and antagonists on the electrically evoked
[3H]over¯ow from these cultures. Whereas the preferential
m-opioid receptor agonist DAGO (1 mmol/L) signi®cantly
inhibited the evoked [3H]over¯ow, the preferential d-opioid
receptor agonist DPDPE (1 mmol/L) showed only a slight
inhibitory tendency. The opioid receptor antagonist
naloxone (0.1 mmol/L) antagonized the effect of DAGO
and, interestingly, enhanced the evoked [3H]over¯ow when
given alone. None of the drugs shown in Fig. 6 affected the
basal out¯ow of [3H].
The effects of drugs binding to purinergic receptors on the
evoked [3H]over¯ow from these cells are shown in Fig. 7.
Both the selective P1-receptor agonist CPA (1 mmol/L) and
the unselective P2-agonist ATP (100 mmol/L) signi®cantly
inhibited the evoked [3H]over¯ow by < 35±40%. Interest-
ingly, however, the effect of not only the P1-agonist CPA,
but also that of the P2-agonist ATP, was antagonized
completely in the presence of the selective P1 antagonist
DPCPX (0.1 mmol/L), which given alone did not affect the
evoked [3H]over¯ow. None of the drugs shown in Fig. 7
affected the basal out¯ow of [3H].
Discussion
It was the aim of this study to establish a model for the
electrically evoked release of Ach from cholinergic
neurones cultured in vitro. For this purpose, septal cells
from the embryonic rat brain (ED 17) were grown in
medium supplemented with NGF and hNT-3 (Hartikka and
Hefti 1988; Nonner et al. 1996; Murata et al. 1998). The
tentative morphological characterization (Fig. 1) of these
septal cultures shows that they represent a mixture of non-
neuronal and neuronal cells. A more detailed phenotypic
characterization of the septal cell cultures was beyond the
scope of this study.
Several lines of evidence support the presence of
cholinergic cells in these cultures: ®rstly, the staining of
some of the cells using an antibody for ChAT (Fig. 1),
secondly, the increase in ChAT activity during cultivation
(Fig. 2), and thirdly, the observation that electrical ®eld
stimulation of these cultures (following pre-incubation with
[3H]choline) elicits an over¯ow of tritium (Fig. 3), which
consisted of < 80% of authentic [3H]Ach. It has been
suggested previously (Molenaar et al. 1973; Richardson and
Szerb 1974), that evoked [3H]over¯ow from cells or tissues
pre-incubated with [3H]choline re¯ects the release of
[3H]Ach. Our present data also show that this evoked
release of Ach was already action potential induced
Fig. 7 Effects of the purine receptor agonists N6-cyclopentyladeno-
sine (CPA; 1 mmol/L) and ATP (100 mmol/L), and of the selective
A1-receptor antagonist 1,8-dipropyl-8-cyclopentylxanthine (DPCPX;
0.1 mmol/L) on the electrically evoked [3H]over¯ow from septal cell
cultures pre-incubated with [3H]choline. Septal cells (DIV 14) were
pre-incubated, superfused and stimulated as shown in Fig. 3. Purine
receptor agonists and antagonists were added to the medium from
16 min before S2 onwards. Their effects are expressed as a percent-
age of the corresponding drug free controls (small symbol with error
bars at the dotted 100% reference line). Signi®cance of differences
versus drug-free controls: ***p , 0.001, or versus CPA (1 mmol/L),
or ATP (100 mmol/L) given alone: 111p , 0.001.
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(tetrodotoxin sensitive) and exocytotic (largely Ca21
dependent) by DIV 7. To our knowledge, this is the ®rst
time that the electrically evoked release of Ach from
cultured septal cells in a continuous superfusion system has
been described.
During growth of the septal cultures tissue accumulation
of [3H]choline increased up to a maximum at DIV 14,
whereas the electrically evoked [3H]over¯ow increased
from DIV 7 to 14 but decreased from DIV 14 to 21
(Fig. 4a). These observations are dif®cult to explain because
changes in high-af®nity [3H]choline uptake and [3H]Ach
synthesis during development have to be taken into account.
Moreover, [3H]choline may also be used by noncholinergic
(and non-neuronal) cells for the synthesis of membrane
lipids. Therefore, it remains to be established whether the
observations depicted in Fig. 4(a) really re¯ect changes in
density or function of cholinergic neurones.
It should be noted, however, that a signi®cant increase in
the inhibitory effects of the muscarinic agonist oxotremorine
(at its IC50 concentration) was observed from DIV 7 to 21,
suggesting an increase in the expression of the muscarinic
autoreceptors during development. Although this ®nding is
only preliminary and has to be con®rmed by further studies,
it supports the time course of the development of muscarinic
autoreceptors observed in vivo in both the hippocampus
(Goldbach et al. 1998) and the septum of rats (Disko et al.
1998, 1999). Furthermore, it underlines the possible useful-
ness of the cell culture model to explore regulatory mech-
anisms in the expression of presynaptic receptors in septal
cholinergic neurones.
A more detailed investigation of the effect of oxo-
tremorine (Fig. 5) revealed that it was atropine sensitive and
hence due to the activation of muscarinic receptors.
Atropine alone did not enhance the evoked Ach release,
suggesting that the concentration of endogenous Ach around
the autoreceptor was < 0, a suggestion also supported by
estimations of this Ach concentration using non-linear
regression analysis of the oxotremorine concentration±
response curve (see Results). Most probably, newly released
Ach is rapidly washed away by the ¯ow of the superfusate,
or metabolized by AchE. The latter possibility seems,
however, to be less probable because the AchE inhibitor
physostigmine added before S2 did not inhibit the evoked
release of Ach.
The IC50 value of oxotremorine on the evoked release of
Ach from cultured cholinergic (septal) neurones was
estimated using non-linear regression analysis (Feuerstein
et al. 1993). The slope parameter c of this analysis was
around unity suggesting a direct proportionality between
receptor occupation and response (Agneter et al. 1997;
Feuerstein and Limberger 1999). Because acetylcholine and
oxotremorine are approximately equipotent at muscarinic
receptors (Cho et al. 1962), it can be assumed (Feuerstein
et al. 1992) that the IC50 value for oxotremorine also re¯ects
its KD value (i.e. pKD, 6.07; 95% con®dence interval, 6.24,
5.85) and that of Ach itself at the autoreceptor. This value
is very similar to the pKD value for oxotremorine at
the muscarinic autoreceptor in rat brain cortex slices
(Albrecht et al. 1999), suggesting that the subtype of
muscarinic autoreceptor in septal cholinergic neurones
cultured in vitro is similar to that observed in the rat brain
cortex in vivo.
In addition to muscarinic autoreceptors, several inhibitory
heteroreceptors, for example m- and d-opioid receptors, as
well as adenosine A1-receptors, have also been described on
cholinergic axon terminals in the rat brain (see Introduc-
tion). In agreement with these observations in vivo, Ach
release from cultured septal cells was also inhibited
following activation of opioid- and adenosine receptors.
However, using the subtype-selective m-agonist DAGO
(Kosterlitz and Paterson 1981) and the d-agonist DPDPE
(Cotton et al. 1985), only m- and no d-opioid receptors could
be detected at DIV 14 (Fig. 6). This ®nding may be related
to the observation that in vivo d-opioid receptors also appear
later in ontogenetic development than m-opioid receptors
(Kornblum et al. 1987; DeVries et al. 1990; Gazyakan et al.
2000b). Interestingly, the preferential m-opioid receptor
antagonist naloxone not only antagonized the effect of
DAGO, but also exhibited signi®cant facilitatory effects
when given alone (Fig. 6). This effect may be due to the
presence of endogenous opioid peptides in the cultures that
tonically activate m-opioid receptors on cholinergic
neurones. Therefore, it seems possible that opioid peptide-
producing neurones occurring in the septal area in vivo
(Augood et al. 1997) also develop in cell cultures from the
embryonic septum.
Because not only the inhibitory effect of the A1 adenosine
receptor agonist CPA (1 mmol/L), but also that of ATP
(100 mmol/L) was antagonized by a low concentration
(0.1 mmol/L) of the A1-receptor antagonist DPCPX, only
inhibitory A1-receptors, and not P2-receptors, seem to
modulate Ach release in cultured septal cells. The inhibitory
effect of ATP may be mediated either directly via the
A1-receptor, or subsequent to a breakdown to adenosine by
an ecto-ATPase associated with cholinergic nerve terminals
(Cunha and Sebastiao 1992). The preferential A1-receptor
antagonist given alone did not enhance the evoked release of
Ach, indicating that, in contrast to K1-evoked Ach release
from cultured amacrine cells (Santos et al. 1998), endo-
genous adenosine does not tonically inhibit the release of
Ach in septal cell cultures.
In conclusion, we have shown that the action-potential
evoked exocytotic release of Ach can be induced by
electrical ®eld stimulation of rat septal cells in culture. In
14-day-old cultures this evoked release of Ach is modulated
via muscarinic autoreceptors, m-opioid and adenosine
A1-receptors. This in vitro model may prove useful in
the exploration of regulatory mechanisms underlying the
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expression of release modulating receptors on septal
cholinergic neurones.
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